Consolidated net loss for the period (Q1) amount -4.57 million compare with the same period (Q1) for the last year amount -2.80 because the Company Cost of Market Development of Expanding the customer base and

3.99% Selling & Administrative Expenses 140.62 196.61 (55.99) (28.48%) Finance Cost 39.52 42.66 (3.14) (7.36%) EBT 165.92 (2.15) 168.06 7,819.16% Tax (24.83) 8.98 33.81 376.55% Total Comprehensive Income

1,701.39 Costs of Sale The company has cost of sales of 1,196.69 million baht, 1,343.99 million baht, and 1,437.41 million baht in year 2017, 2018, and 2019 respectively. The cost of sales to revenue from

the follow main reasons. 1. Revenue from hospital operations increased by Baht 102.22 million or 4.52 % due to in 2018 the general patients of Company and subsidiaries increased. 2. Cost of hospital

last year totaling 4.29 million Baht or 27.31% (Hospitality business revenue was 15.71 million Baht for the year ended December 31, 2017). Cost of goods sold The company recorded cost of goods sold of

of 2018 1 st quarter of 2017 Rental and services income 923.51 785.16 Cost 704.71 566.74 Gross profit 218.80 218.42 Gross profit margin 23.69% 27.82% Gross profit of the Company’s rental and service

or 14.80 percent.  Expenses Cost of Sales The Company and its subsidiaries' cost of real estate was in the amount of Baht 261.31 million, decreased by Baht 26.48 million or 11.28 percent, compared to

2.19 million or 8.96% compared to prior year because of cost efficiency management. Please be informed accordingly. Sincerely yours, (Mr. Aukarachai Taupradist) Deputy General Manager

approximately 24.20 million Baht due to the cost of transportation in the country by land and the cost of producing dialysis for 6 months period included but no mentioned cost in year 2017. Also the Company is in

revenue Cost of sales Cost of goods sold consists of raw material and packaging, salary and wage of production staff, depreciation of property, plant and equipment, transportation and logistics and other